Published 11/04/2009 by Globe and Mail
Canada's flu vaccine leftovers being sent overseas
A picture of a syringue and two flasks of Pandemrix A (H1N1) vaccine from Glaxo Smith Kline. AFP/
Manufacturer exporting excess antigen, the vaccine's key component, because it's producing more of it than it can actively put into vials
Email
Please enter a valid e-mail address
Please enter...
Share this
What others report on the same story